Alcidion Corporation a leading health informatics company based in Adelaide is set to list on the Australian Stock Exchange next month, following the successful RTO of Naracoota Resources.
The Premier of South Australia, the Hon. Jay Weatherill MP is set to officially welcome Alcidion Group Ltd on to the Australian Stock Exchange at an exclusive event at “The Science Exchange” on Wednesday, 27th January 2016.
Over the past decade, under the stewardship of Professor Malcolm Pradhan and Mr. Ray Blight, the former Chief Executive of the SA Health Commission, Alcidion has invested in excess of $15m in the Research & Development of the cutting edge Clinical Decision Support System (CDSS) that is embedded in the Miya Platform suite. Beginning in 2016, The US Federal Government will progressively reduce funding to hospitals that have not adopted and deployed this technology. As a result, IndustryARC estimates that the CDSS market will grow at a CAGR of 21.5% from $USD1.18b to $USD4.65b by the end of the decade.
Hospitals are built upon an eco-system of disparate Clinical Information Systems (CIS), workflows are inherently complex and fluctuate based on each patient’s differential diagnosis and modality. Alcidion’s Miya Platform integrates disparate CIS, to mitigate emerging clinical risk and present this clinical intelligence across a continuum of devices, from large format televisions through to mobile devices.
Miya is the brainchild of Malcolm Pradhan, an adjunct professor in health informatics at the University of South Australia, and Ray Blight, former CEO and Chairman of the South Australian Health Commission.
Professor Malcolm Pradhan holds a PhD from Stanford University in Medical Informatics and was recently a clinical lead for the National e-Health Transition Authority as is considered a global authority on Clinical Decision Support. Professor Pradhan commented “Health care will be unsustainable due to generational changes with a three to four times increase in complex patients – the only viable solution to develop a sustainable health care environment requires that health informatics play an integral role in health care delivery.
Alcidion’s Chief Executive and former Chair of the SA Health Commission, Mr Ray Blight commented “Health care is primarily about risk management: Detection, monitoring and mitigation. An informatics platform should play a more active role in assisting clinicians.“
Mr Blight, who co-founded Alcidion with Professor Pradhan in 2000, said Miya has been designed as a health informatics platform that is able to extract information about a particular patient and highlight their clinical risk factors in order to provide real-time clinical decision support – what many in the health IT sector consider the nirvana of healthcare technology. “The Miya Platform is about helping the clinician understand a patient’s clinical risk so they can make the best possible decisions,” Mr Blight said. “We are able to gather expert knowledge about a particular condition and present that in the context of a specific patient, thereby assisting the clinician in making the best possible care decisions.”.
Alcidion has used a Victorian government innovation grant to develop the intelligent patient journey system (iPJS) that is being used by Western Health at Footscray, Sunshine and Williamstown hospitals. The system is now deployed in every ward in Western Health’s three acute hospitals, with three modes of clinician dashboard being available to clinicians and care teams.
“We have a desktop view, which is most commonly used at the nurse work station or ward work station, and there is also a very large digital display option which is excellent for clinical handover where you might have half a dozen members of the care team standing around, reviewing patients one by one,” Mr Blight said.
“It can also be accessed directly from iPad Minis so that any clinician can go to the bedside, review the patient at the bedside, record their actions, record their decisions, etc – and by early next year they will be able to place best practice orders for pathology over those mobile devices, direct from the bedside.”
For further information, please contact:
Nathan Buzza, Executive Director
Tel: 08 8208 4600
Alcidion Corporation
nathan.buzza(at)alcidion(dot)com
Ray Blight, Chief Executive Officer
Tel: 08 8208 4600
Alcidion Corporation
ray.blight(at)alcidion(dot)com